← FDA DRUG APPROVALS

FDA NDA · NDA019229

ZINC SULFATE

Sponsor: ABRAXIS PHARM

APPLICATION
NDA019229
TYPE
NDA
ORIGINAL APPROVAL
1987-05-05
LATEST ACTION
1989-06-06
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ZINC SULFATEDiscontinued
ZINC SULFATE EQ 1MG ZINC/ML · INJECTABLE · INJECTION

Approval history

1989-06-06Labeling · Supplement 1 · standardAP
1987-05-05Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →